BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 106 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $3,212,000 | -73.8% | 47,000 | -67.1% | 0.28% | -70.9% |
| Q4 2020 | $12,257,000 | +46.7% | 143,000 | +11.3% | 0.96% | +40.4% |
| Q3 2020 | $8,354,000 | -21.5% | 128,500 | -11.7% | 0.68% | -50.3% |
| Q2 2020 | $10,638,000 | +322.5% | 145,500 | +96.6% | 1.38% | +184.7% |
| Q1 2020 | $2,518,000 | -45.6% | 74,000 | -12.9% | 0.48% | -46.0% |
| Q4 2019 | $4,628,000 | +46.0% | 85,000 | +11.8% | 0.89% | +34.0% |
| Q3 2019 | $3,170,000 | -35.9% | 76,000 | -32.7% | 0.67% | -31.3% |
| Q2 2019 | $4,943,000 | +35.2% | 112,893 | +59.0% | 0.97% | +30.7% |
| Q1 2019 | $3,655,000 | +23.3% | 71,000 | -5.3% | 0.74% | +30.4% |
| Q2 2018 | $2,964,000 | – | 75,000 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |